Orthopaedic Hemophilia Treatment Center — Los Angeles, California

Orthopaedic Hemophilia Treatment Center is a clinical research site located in Los Angeles, California, United States.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Orthopaedic Hemophilia Treatment Center has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Hemophilia A, Hemophilia B, Hemophilia A With Inhibitors.

Sponsors: OPKO Health, Inc., Baxalta now part of Shire, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Orthopaedic Hemophilia Treatment Center?

Orthopaedic Hemophilia Treatment Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Orthopaedic Hemophilia Treatment Center conducted?

Orthopaedic Hemophilia Treatment Center has 5 clinical trials on record, with 2 currently active. Their work covers Hemophilia A, Hemophilia B, Hemophilia A With Inhibitors.

Is Orthopaedic Hemophilia Treatment Center accredited by Crixeo Health?

Orthopaedic Hemophilia Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Orthopaedic Hemophilia Treatment Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.